Multi User License - $2,999
Revascularization device is a neurovascular self-expanding, retrievable device that resembles a stent and is used to reestablish blood flow in patients who have suffered an ischemic stroke due to a major intracranial artery obstruction.
The global stroke revascularization device market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
The Solitaire X Revascularization Device has been made available, and Medtronic plc has announced its first patient trials for the treatment of acute ischemic stroke. Doctors have been able to help patients with stroke have a higher chance of recovering because of the industry-leading Solitaire Revascularization Device.
The fourth generation of the Solitaire family of revascularization devices, Solitaire X, keeps the technical features that have made them very successful and clinically validated while incorporating an optimized distribution method for increased efficiency.
Additionally, Medtronic unveils the Phenom 21 Catheter, a microcatheter with a length of 160 cm that can deliver all sizes of Solitaire X.Patients who have experienced an acute ischemic stroke with a major artery occlusion can regain blood flow by using the Solitaire X device, which mechanically eliminates blood clots from blocked brain vessels.
Solitaire X offers a reduced clot crossing profile and seamless distribution to occlusions in distal arteries as small as 2.0 mm when used in conjunction with Phenom 21. With this suitable system, Medtronic is even more dedicated to the fight against stroke
The Tigertriever Revascularization Device (RD), made by Rapid Medical Ltd., a subsidiary of MicroPort NeuroTech Co., Ltd.. Tigertriever is a totally retrievable medical gadget created to help patients with acute ischemic strokes regain blood flow. The mesh’s outer diameter is regulated by a handle, unlike any previous commercial device.
Furthermore, Tigertriever is the only commercially available product that makes use of a unique 3D braided technique to build a mesh with a large pore size for optimal clot penetration. Tigertriever is made of an expandable wire shaft attached on a collapsible, totally retrievable, fine wire structure. A microcatheter is used to deliver the device intracranially.
A suite of three devices called CERENOVUS Stroke Solutions, part of Johnson & Johnson Medical Devices Companies, has been introduced to help doctors perform clot removal treatments. With compatibility in mind, CERENOVUS Stroke Solutions were created to aid medical professionals in performing mechanical thrombectomy treatments.
The range of technologies consists of: The newest generation stent retriever, the EMBOTRAP III Revascularization Device, is made to engage a variety of clot types, boost procedural confidence, and offer more specialised alternatives to accomplish the First Pass Effect (FPE)
The latest component of Penumbra, Inc.’s extensive Penumbra System, the RED 62 Reperfusion Catheter, has received approval from the U.S. Food and Drug Administration and is now commercially available. Penumbra, Inc. is a worldwide healthcare company with a focus on cutting-edge therapeutics.
Together with Penumbra ENGINE, RED 62 is made to manoeuvre through difficult distal artery anatomy and deliver forceful aspiration for the removal of blood clots in acute ischemic stroke patients with big vessel occlusions.
It is designed to help revascularize patients who have experienced an acute ischemic stroke due to intracranial major vessel occlusions. Reperfusion Catheters, 3D Revascularization Device, Penumbra ENGINE aspiration source, and other accessories are included with the Penumbra System.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.